PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
31-Jul-2025 Medacta Group SA reports continued above-market revenue growth of 19.8% in constant currency in H1 2025 and upgrades its FY 2025 and mid-term guidance Medacta Group SA
31-Jul-2025 FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study Curatis Holding AG
30-Jul-2025 Medartis 2025 half-year results webcast Medartis Holding AG
30-Jul-2025 Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site Evotec SE
30-Jul-2025 Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site Evotec SE
30-Jul-2025 Formycon invites to conference call on 2025 half-year results and announces participation in international investor conferences in the 3rd quarter of 2025 Formycon AG
29-Jul-2025 Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority Viromed Medical AG
29-Jul-2025 Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 Eckert & Ziegler SE
29-Jul-2025 Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC SYNBIOTIC SE
29-Jul-2025 MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy MetrioPharm
29-Jul-2025 Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years Drägerwerk AG & Co. KGaA
29-Jul-2025 Relief Therapeutics Announces Proposed Business Combination with NeuroX, successor to MindMaze Relief Therapeutics Holding SA
29-Jul-2025 AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland confirms its growth momentum in the first half of 2025 and improves profitability AEVIS VICTORIA SA
28-Jul-2025 Abivax Announces Closing of $747.5 Million Public Offering ABIVAX
28-Jul-2025 Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Nyxoah SA.
28-Jul-2025 PharmaSGP Holding SE publishes joint reasoned statement of the Management Board and Supervisory Board on the public delisting tender offer by FUTRUE GmbH PharmaSGP Holding SE
28-Jul-2025 Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation. Eckert & Ziegler SE
25-Jul-2025 Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) ABIVAX
24-Jul-2025 Abivax announces trading resumption of its ordinary shares on Euronext Paris ABIVAX
24-Jul-2025 Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares ABIVAX